前药。 2021; 12：669362。 EPUB 2021 5月28日。PMID： 34122090“> 34122090 K Pawar，Samragni S Pawar，Rahul R Bhoite，Ramesh R Bhoite，Meenal V Kulkarni，Aditi r deshpande
文章隶属关系：kirti s pawar
摘要：摘要：coronavirus sishial-coronavirus siseal-coronavirus siseal-coronavirus nivery-coronavirus siseal-coronavirus sishial-2019（covid-19）范围广泛。姜黄素是姜黄（姜黄）的活性组成部分，具有多种特性，包括抗炎，抗氧化剂，抗病毒，抗血栓形成和抗增殖作用，使其成为T的有前途的候选者he symptomatic treatment of COVID-19.We aimed to determine the effects of curcumin administered with piperine (to optimize absorption) on symptoms in patients with COVID-19 in a double-blind, randomized, controlled trial at a 30-bed dedicated COVID Health Center (DCHC) in Maharashtra, India.In addition to conventional COVID-19 treatment, patients in the control group received a dose of probiotics twice a day,研究组中的患者每天两次接受卷蛋白（2.5 mg）的姜黄素（525 mg）。评估了住院持续时间的姜黄素/毕生氨酸治疗对一级和继发性结果的影响。接受姜黄素/杂氨酸治疗的轻度，中度和严重症状的患者表现出早期的症状恢复（发烧，咳嗽，咳嗽，喉咙痛和呼吸困难和呼吸困难），较少的恶化，较少的临床效果，以及在94％的临床上，较少的临床效果，较少的临床效果，而造成了94％的持续性，较少的临床效果，较少的糖尿病效果。控制g小组。 Furthermore, curcumin/piperine treatment appeared to reduce the duration of hospitalization in patients with moderate to severe symptoms, and fewer deaths were observed in the curcumin/piperine treatment group.Administration of oral curcumin with piperine as an adjuvant symptomatic therapy in COVID-19 treatment could substantially reduce morbidity and mortality, and ease the logistical and supply-related burdens on the healthcare 系统。姜黄素可能是防止后血栓栓塞事件的安全自然治疗选择。CTRI/2020/05/025482。